C646, a histone acetyltransferase p300 inhibitor acting as a p53 activation inhibitor, significantly increased viral production in p53 wild-type cancer cells (Fig. 4K), and decreased cell viability (Fig. 4L), suggesting that inhibition of p53 activation also enhanced cell death derived from viral lysis. This evidence concerns the gene TP53 and cancer.